Micron's Post-Earnings Drop Masks Structural Doubts

What happened

Micron's stock fell over 10% after fiscal Q3 results beat expectations and Q4 guidance was strong, with record revenue of $41.5B and 84.6% gross margin. However, the market is pricing in concerns about the durability of the cycle. The DeepValue report notes that while HBM4 is ramping and strategic customer agreements (SCAs) are progressing, only ~20% of DRAM volume is under contract, and ceiling prices cap upside. The pullback reflects a growing disconnect between stellar near-term execution and the risk that the memory cycle might peak earlier than anticipated. Zacks frames it as a buying opportunity, but the DeepValue analysis suggests waiting for either a lower entry near $780 or confirmation of broader SCA adoption and HBM wins.

Implication

Investors should remain on the sidelines until Micron demonstrates meaningful progress on SCA coverage (adding at least 4 SCAs and deposit commitments above $26B) or the stock pulls back to the ~$780 attractive entry zone. The current price, near $925, embeds high expectations for continued scarcity and margin expansion. Any signs of HBM softening or incomplete contract growth could drive further downside to $720. The pullback is not a buying signal unless the thesis triggers are met within the next 6 months.

Thesis delta

The post-earnings selloff reinforces our WAIT stance. It does not change the fundamental thesis; rather, it confirms that the market is already discounting perfection. The key delta is that the stock is now closer to our base case implied value of $950, but still offers no margin of safety. The pullback reduces some of the speculative froth, but the core uncertainties around contract coverage and capacity timing remain unresolved. Investors should require new catalysts—such as additional SCAs or HBM4 wins—before committing capital.